<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="50398">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02072629</url>
  </required_header>
  <id_info>
    <org_study_id>E-22746</org_study_id>
    <nct_id>NCT02072629</nct_id>
  </id_info>
  <brief_title>HCU: Can VHVs Trained in ICCM Improve Care for Children</brief_title>
  <acronym>HCU:VHV/ICCM</acronym>
  <official_title>Healthy Child Uganda: Can Village Health Volunteers Trained in Integrated Community Case Management of Childhood Illness Improve Access to Care for Africa's Most Vulnerable Children?</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Calgary</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Mbarara University of Science and Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Calgary</source>
  <oversight_info>
    <authority>Canada: Health Canada</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will assess how the current VHV (VHV=CHW, community health worker) scope can be
      expanded to include iCCM and if such group interventions can provide improved access to
      treatment for children.

      In rural SW Uganda,  can iCCM provided by lay volunteers, increase the proportion of
      children with diarrhoea receiving ORS/Zn, ARI receiving anti-biotics, and fever/malaria
      receiving anti-malarials?
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>November 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">December 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Health Services Research</study_design>
  <primary_outcome>
    <measure>Absolute change pre/post intervention (VHV ICCM training) in proportion of U5s receiving (a) antimalarial for fever (b) ORS/Zn for diarrhea (c) Abx for pneumonia</measure>
    <time_frame>pre- (Dec 2010) post- (Dec 2012) intervention (2 years)</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Actual">4071</enrollment>
  <condition>Diarrhoea</condition>
  <condition>Pneumonia</condition>
  <condition>Malaria</condition>
  <arm_group>
    <arm_group_label>Training of VHVs in iCCM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>In these villages VHVs will be provided with iCCM training and equipped to support iCCM in their villages</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Training of VHVs in iCCM</intervention_name>
    <description>Village Health Volunteers will be trained in Integrated Community Case Management (iCCM) of childhood illness</description>
    <arm_group_label>Training of VHVs in iCCM</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Women living in intervention and comparison villages

          -  Mother to at least one child under 59 months old

        Exclusion Criteria:

        -No living child
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Samuel Maling, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Mbarara University of Science and Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>jenn Brenner, MD</last_name>
    <role>Study Director</role>
    <affiliation>University of Calgary</affiliation>
  </overall_official>
  <verification_date>February 2014</verification_date>
  <lastchanged_date>February 25, 2014</lastchanged_date>
  <firstreceived_date>February 21, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Calgary</investigator_affiliation>
    <investigator_full_name>Jennifer L. Brenner</investigator_full_name>
    <investigator_title>Clinical Associate Professor</investigator_title>
  </responsible_party>
  <keyword>Antimalarials</keyword>
  <keyword>Antibiotics</keyword>
  <keyword>ORS Zn</keyword>
  <keyword>Village Health Volunteers</keyword>
  <keyword>Integrated Community Case Management</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Diarrhea</mesh_term>
    <mesh_term>Malaria</mesh_term>
    <mesh_term>Pneumonia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
